Bio Break: How Nature-Inspired Biosensors Are Revolutionizing Medical Devices
In this episode of Bio Break, Nick and Joris dive into the fascinating realm of biosensors, showcasing how nature’s biological processes inspire groundbreaking innovations in medical device technology. From jellyfish to fireflies, the natural world has provided invaluable tools that are transforming diagnostics and research.
The discussion kicks off with green fluorescent protein (GFP), a revolutionary biosensor derived from jellyfish. Discovered in the 1960s and popularized in the 1990s, GFP earned its place in history with a Nobel Prize. This remarkable protein fluoresces when exposed to specific wavelengths of light, enabling scientists to monitor cellular activities. GFP has become an indispensable tool for tracking cellular processes, from observing metabolic activities to measuring changes in pH levels. Joris shares an example from his PhD research, where he utilized a modified GFP to measure the redox state of cells, highlighting the protein’s adaptability and utility.
The conversation shifts to luminescence, drawing inspiration from fireflies and their ability to emit light through biochemical reactions. This phenomenon, known as bioluminescence, has been harnessed in medical research to create biosensors that can emit light when specific chemical reactions occur. Joris discusses how luminescent molecules, such as luciferase, have played pivotal roles in cancer research and diagnostics. A newer innovation, NanoLuc, inspired by deep-sea shrimp, has taken luminescence to the next level with its smaller, brighter design, enabling more efficient and precise applications.
This episode highlights how the interplay of biology and engineering continues to unlock new possibilities in diagnostics and medical devices. By mimicking nature’s ingenuity, biosensors are paving the way for non-invasive, accurate, and efficient tools for understanding and monitoring health.
Related Resources
Nick and Nigel breaks down what actually goes into the cost of getting a sterilized device into a user’s hands, and why up to 30% of costs can sit in places most teams don’t plan for.
Theranostics combines diagnosis and therapy into a single targeting system, using one ligand to attach to two different radioactive payloads, one for imaging and one for treatment. It represents a significant shift in how cancer is being identified and treated. But the theranostics delivery workflow tells a different story.
Most medical devices were designed for clinical settings, not the patients and caregivers who increasingly rely on them at home. Here’s what good home-use device design actually requires.
How do you measure comfort in medical device design? Explore the tools, scales, and study design principles that turn a subjective experience into actionable design data.